药物对比
Canagliflozin vs Ertugliflozin
比较 Canagliflozin（Invokana）与 Ertugliflozin（Steglatro）作为SGLT2抑制剂治疗2型糖尿病，注意黑框警告的差异及复方品牌。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting or switching between SGLT2 inhibitors for type 2 diabetes, considering combination products and safety profiles.
结论
Both Canagliflozin and Ertugliflozin provide comparable SGLT2 inhibition for glycemic control, with neither universally superior based on individual risks.
全部药物对比